Syncom Formulations Fixes Record Date for 10% Dividend, AGM on Sep 30
Syncom Formulations has fixed September 23, 2026, as the record date for a 10% dividend (Rs. 0.10/share) for FY26. The 38th AGM will be held on September 30, 2026, via VC/OAVM for dividend approval. Shareholders can waive dividends by September 26, 2026.
The dividend is a small percentage (10%) and a nominal amount (Rs. 0.10 per share), indicating a low financial impact on the company and shareholders.
The announcement concerns the payment of a dividend, which is generally viewed positively by shareholders.
Syncom Formulations (India) Limited has announced the record date for determining entitlement to a 10% dividend (Rs. 0.10 per equity share of Rs. 1 each) for the financial year 2025-26. The record date is set for Wednesday, September 23, 2026.
This dividend is subject to the approval of shareholders at the upcoming 38th Annual General Meeting (AGM). Shareholders who wish to waive their dividend entitlement must submit a duly filled and signed Dividend Waiver Form to the company or its Registrar and Transfer Agent (RTA) by September 26, 2026.
The 38th AGM of the company is scheduled to be held on Wednesday, September 30, 2026, at 2:00 PM via Video Conferencing (VC)/Other Audio-Visual Means (OAVM). The announcement was made on August 11, 2026.
What to do with a filing like this
Syncom Formulations (India) Limited filed this with the NSE as a statutory disclosure, categorised under dividend. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Syncom Formulations (India) Limited. Read the original for the full detail.